Hollister Research Study for Intermittent Catheter Users

Posted by Reeve Staff in Daily Dose on May 13, 2021 # Health

Hollister Incorporated will be conducting the 6009 Intermittent Catheter Study, which is an at-home product use study. The purpose of this study is to collect information from intermittent catheter users who want to share their opinion on potential product modifications. Your participation in this study will contribute to the final design of the intermittent catheter being tested. Find out if you qualify to participate below.

Who May Participate?

  • You are male, 18 years or older, and currently use a hydrophilic intermittent catheter. Some examples include but are not limited to:
    • VaPro Plus™ or VaPro Plus Pocket™ No Touch Intermittent Catheter (Hollister Incorporated)
    • Onli™ Intermittent Catheter (Hollister Incorporated)
    • Apogee HC™ Intermittent Catheter (Hollister Incorporated)
    • SpeediCath® Standard (Coloplast)
    • GentleCath™ Glide (ConvaTec)
    • Hydrophilic Cure Catheter® (Cure Medical)
    • LoFric® Hydro-Kit™ Intermittent Catheter (Wellspect HealthCare)
    • LoFric® Origo™ Intermittent Catheter (Wellspect HealthCare)
  • You are willing to have the study product shipped to your home, use the product, and complete online questionnaires about your experience. Email address is required for online questionnaires.
  • If you qualify and participate in the study, you will receive an electronic or physical gift card after completing the study.

If you are interested in participating in the study, please email Hillary Marhoefer at [email protected] with "6009 Study- Reeve" in the subject line of your email and include the manufacturer and product number of your current intermittent catheter.

This blog is sponsored by Hollister.

The National Paralysis Resource Center website is supported by the Administration for Community Living (ACL), U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $8,700,000 with 100 percent funding by ACL/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by ACL/HHS, or the U.S. Government.